Response to: Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”

Abstract EN

In a recent Letter to the Editor [1], Talebi Bezmin Abadi commented on the paper by Arama et al.

[2], in which the authors concluded that a 2-week regimen (Proton Pump inhibitor, plus Clarithromycin plus Amoxicillin) is preferable to a 7-day regimen as first-line therapy for Helicobacter pylori (H.

pylori) infection.

In his Letter, Talebi Bezmin Abadi concluded that “Certainly, preantibiotic susceptibility tests are inevitable approach in H.

pylori therapy.” Although we agree with all comments, we found the conclusion inappropriate.